I Frontera Therapeutics announced today that its proprietary recombinant adeno-associated virus (rAAV) gene therapy, FT-003 Injection, has ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, ...

Jiarui Nie, a postdoctoral researcher at the National Institutes of Health, is exploring how gold nanoparticles injected into ...

Raising money for the Retina Foundation of the Southwest in Dallas is deeply personal for Dan Hunt, president of FC Dallas ...

Intraocular inflammation occurred more frequently with 8-mg aflibercept (Eylea) compared with what was observed in previous ...

At the ARVO 2025 meeting in Salt Lake City, Utah, Nimesh Patel, MD, presented on the LUCIA and LUGANO phase 3 pivotal trials ...

In today’s fast-paced world, maintaining optimal eye health is more crucial than ever. With the increasing screen time and ...

A new study shows that tiny gold particles could circumvent damaged photoreceptors in patients with macular degeneration and ...

Retina World Congress 2025 unites global retina experts in Fort Lauderdale to explore cutting-edge research, surgical ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...